US Stock MarketDetailed Quotes

VIR Vir Biotechnology

Watchlist
  • 7.960
  • -0.110-1.36%
Close Mar 7 16:00 ET
  • 8.000
  • +0.040+0.50%
Post 20:01 ET
1.09BMarket Cap-2.08P/E (TTM)

Vir Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
42.69%-446.35M
18.80%-87.64M
-10.04%-171.48M
80.00%-77.85M
13.03%-109.39M
-146.82%-778.79M
-407.26%-107.93M
-232.17%-155.83M
-140.54%-389.25M
-122.87%-125.78M
Net income from continuing operations
15.14%-521.96M
9.82%-104.59M
-30.78%-213.72M
28.95%-138.38M
53.69%-65.28M
-219.25%-615.12M
-14.14%-115.97M
-193.21%-163.41M
-154.63%-194.78M
-127.18%-140.96M
Depreciation and amortization
-25.15%14.56M
-35.57%2.89M
-36.85%2.9M
-10.28%4.26M
-19.88%4.52M
186.76%19.45M
129.34%4.48M
172.65%4.59M
197.49%4.75M
263.27%5.64M
Deferred tax
-177.42%-2.95M
-148.64%-2.64M
--57K
----
----
93.00%-1.06M
---1.06M
--0
----
----
Other non cash items
251.23%17.57M
-89.22%2.32M
161.30%7.01M
-46.62%4.64M
111.86%3.61M
-104.06%-11.62M
64.37%21.53M
71.95%-11.43M
-97.88%8.69M
68.13%-30.41M
Change In working capital
72.42%-84.01M
48.09%-17M
158.91%17.49M
99.07%-2.35M
-865.94%-82.15M
-145.78%-304.59M
-125.23%-32.75M
46.01%-29.69M
-143.11%-252.88M
174.02%10.73M
-Change in receivables
-1,052.74%-6.51M
-142.57%-8.75M
---54K
183.65%2.69M
-119.16%-401K
-100.07%-565K
-101.30%-3.61M
--0
-99.89%948K
100.47%2.09M
-Change in prepaid assets
-84.32%10.19M
-61.87%4.11M
-108.11%-2.18M
-63.93%6.42M
-80.68%1.83M
265.07%64.97M
121.39%10.78M
63.06%26.9M
440.77%17.81M
3,943.32%9.49M
-Change in payables and accrued expense
96.83%-11.28M
108.88%3.28M
140.92%22.37M
97.13%-7.66M
-1,257.75%-29.27M
-2,317.55%-355.77M
52.54%-36.95M
35.43%-54.68M
7.91%-266.66M
-99.42%2.53M
-Change in other current assets
-83.66%353K
-121.68%-501K
-18.61%1.74M
-166.22%-796K
95.67%-86K
118.32%2.16M
127.64%2.31M
162.86%2.13M
-260.75%-299K
-774.01%-1.98M
-Change in other current liabilities
-76.51%-23.03M
-301.63%-12.6M
21.69%-2.88M
-11.41%-3.49M
-30.98%-4.07M
-137.11%-13.05M
-6.13%-3.14M
-139.41%-3.68M
-503.08%-3.13M
-529.82%-3.11M
-Change in other working capital
-2,191.30%-53.73M
-19.11%-2.55M
-307.86%-1.51M
131.38%482K
-3,050.53%-50.16M
92.96%-2.35M
75.67%-2.14M
99.08%-369K
23.92%-1.54M
-90.33%1.7M
Cash from discontinued investing activities
Operating cash flow
42.69%-446.35M
18.80%-87.64M
-10.04%-171.48M
80.00%-77.85M
13.03%-109.39M
-146.82%-778.79M
-407.26%-107.93M
-232.17%-155.83M
-140.54%-389.25M
-122.87%-125.78M
Investing cash flow
Cash flow from continuing investing activities
203.33%499.37M
234.28%140.74M
301.18%118.6M
-8.12%211.61M
-71.02%28.42M
113.79%164.63M
31.56%-104.81M
91.10%-58.95M
184.57%230.32M
193.06%98.08M
Net PPE purchase and sale
81.79%-3.93M
103.13%48K
36.70%-2.35M
96.97%-287K
80.50%-1.34M
68.28%-21.57M
87.81%-1.54M
80.43%-3.71M
54.09%-9.46M
56.62%-6.87M
Net investment purchase and sale
170.30%503.3M
235.83%140.28M
319.71%121.37M
-11.63%211.89M
-71.64%29.76M
116.54%186.2M
26.51%-103.28M
91.42%-55.24M
195.25%239.77M
217.18%104.95M
Cash from discontinued investing activities
Investing cash flow
203.33%499.37M
234.28%140.74M
301.18%118.6M
-8.12%211.61M
-71.02%28.42M
113.79%164.63M
31.56%-104.81M
91.10%-58.95M
184.57%230.32M
193.06%98.08M
Financing cash flow
Cash flow from continuing financing activities
-41.34%4.39M
-24.82%1.26M
-88.81%31K
-7.46%2.94M
-93.52%152K
-78.48%7.48M
-16.46%1.68M
-86.05%277K
3.21%3.18M
-91.53%2.34M
Net issuance payments of debt
----
----
39.39%-40K
-1.47%-69K
-4.55%-69K
----
----
-11.86%-66K
-13.33%-68K
-3.13%-66K
Net common stock issuance
--0
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
-41.38%4.55M
-29.26%1.25M
-79.30%71K
-10.04%3.01M
-90.43%221K
0.14%7.77M
-15.37%1.77M
-83.22%343K
6.59%3.35M
377.27%2.31M
Net other financing activities
42.51%-165K
----
----
----
----
80.30%-287K
----
----
----
108.35%100K
Cash from discontinued financing activities
Financing cash flow
-41.34%4.39M
-24.82%1.26M
-88.81%31K
-7.46%2.94M
-93.52%152K
-78.48%7.48M
-16.46%1.68M
-86.05%277K
3.21%3.18M
-91.53%2.34M
Net cash flow
Beginning cash position
-69.90%261.29M
-44.04%264.33M
-53.82%317.18M
-78.58%180.47M
-69.90%261.29M
138.84%867.97M
-52.00%472.35M
-55.01%686.86M
0.82%842.61M
138.84%867.97M
Current changes in cash
109.46%57.4M
125.76%54.37M
75.36%-52.85M
187.77%136.7M
-218.70%-80.82M
-220.24%-606.68M
-81.95%-211.06M
60.48%-214.51M
-122.54%-155.75M
-105.37%-25.36M
End cash Position
21.97%318.7M
21.97%318.7M
-44.04%264.33M
-53.82%317.18M
-78.58%180.47M
-69.90%261.29M
-69.90%261.29M
-52.00%472.35M
-55.01%686.86M
0.82%842.61M
Free cash flow
43.32%-453.65M
17.74%-90.04M
-8.96%-173.84M
80.31%-78.51M
16.12%-111.26M
-150.17%-800.36M
-585.38%-109.46M
-261.30%-159.54M
-142.44%-398.7M
-124.83%-132.65M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 42.69%-446.35M18.80%-87.64M-10.04%-171.48M80.00%-77.85M13.03%-109.39M-146.82%-778.79M-407.26%-107.93M-232.17%-155.83M-140.54%-389.25M-122.87%-125.78M
Net income from continuing operations 15.14%-521.96M9.82%-104.59M-30.78%-213.72M28.95%-138.38M53.69%-65.28M-219.25%-615.12M-14.14%-115.97M-193.21%-163.41M-154.63%-194.78M-127.18%-140.96M
Depreciation and amortization -25.15%14.56M-35.57%2.89M-36.85%2.9M-10.28%4.26M-19.88%4.52M186.76%19.45M129.34%4.48M172.65%4.59M197.49%4.75M263.27%5.64M
Deferred tax -177.42%-2.95M-148.64%-2.64M--57K--------93.00%-1.06M---1.06M--0--------
Other non cash items 251.23%17.57M-89.22%2.32M161.30%7.01M-46.62%4.64M111.86%3.61M-104.06%-11.62M64.37%21.53M71.95%-11.43M-97.88%8.69M68.13%-30.41M
Change In working capital 72.42%-84.01M48.09%-17M158.91%17.49M99.07%-2.35M-865.94%-82.15M-145.78%-304.59M-125.23%-32.75M46.01%-29.69M-143.11%-252.88M174.02%10.73M
-Change in receivables -1,052.74%-6.51M-142.57%-8.75M---54K183.65%2.69M-119.16%-401K-100.07%-565K-101.30%-3.61M--0-99.89%948K100.47%2.09M
-Change in prepaid assets -84.32%10.19M-61.87%4.11M-108.11%-2.18M-63.93%6.42M-80.68%1.83M265.07%64.97M121.39%10.78M63.06%26.9M440.77%17.81M3,943.32%9.49M
-Change in payables and accrued expense 96.83%-11.28M108.88%3.28M140.92%22.37M97.13%-7.66M-1,257.75%-29.27M-2,317.55%-355.77M52.54%-36.95M35.43%-54.68M7.91%-266.66M-99.42%2.53M
-Change in other current assets -83.66%353K-121.68%-501K-18.61%1.74M-166.22%-796K95.67%-86K118.32%2.16M127.64%2.31M162.86%2.13M-260.75%-299K-774.01%-1.98M
-Change in other current liabilities -76.51%-23.03M-301.63%-12.6M21.69%-2.88M-11.41%-3.49M-30.98%-4.07M-137.11%-13.05M-6.13%-3.14M-139.41%-3.68M-503.08%-3.13M-529.82%-3.11M
-Change in other working capital -2,191.30%-53.73M-19.11%-2.55M-307.86%-1.51M131.38%482K-3,050.53%-50.16M92.96%-2.35M75.67%-2.14M99.08%-369K23.92%-1.54M-90.33%1.7M
Cash from discontinued investing activities
Operating cash flow 42.69%-446.35M18.80%-87.64M-10.04%-171.48M80.00%-77.85M13.03%-109.39M-146.82%-778.79M-407.26%-107.93M-232.17%-155.83M-140.54%-389.25M-122.87%-125.78M
Investing cash flow
Cash flow from continuing investing activities 203.33%499.37M234.28%140.74M301.18%118.6M-8.12%211.61M-71.02%28.42M113.79%164.63M31.56%-104.81M91.10%-58.95M184.57%230.32M193.06%98.08M
Net PPE purchase and sale 81.79%-3.93M103.13%48K36.70%-2.35M96.97%-287K80.50%-1.34M68.28%-21.57M87.81%-1.54M80.43%-3.71M54.09%-9.46M56.62%-6.87M
Net investment purchase and sale 170.30%503.3M235.83%140.28M319.71%121.37M-11.63%211.89M-71.64%29.76M116.54%186.2M26.51%-103.28M91.42%-55.24M195.25%239.77M217.18%104.95M
Cash from discontinued investing activities
Investing cash flow 203.33%499.37M234.28%140.74M301.18%118.6M-8.12%211.61M-71.02%28.42M113.79%164.63M31.56%-104.81M91.10%-58.95M184.57%230.32M193.06%98.08M
Financing cash flow
Cash flow from continuing financing activities -41.34%4.39M-24.82%1.26M-88.81%31K-7.46%2.94M-93.52%152K-78.48%7.48M-16.46%1.68M-86.05%277K3.21%3.18M-91.53%2.34M
Net issuance payments of debt --------39.39%-40K-1.47%-69K-4.55%-69K---------11.86%-66K-13.33%-68K-3.13%-66K
Net common stock issuance --0------------------0----------------
Proceeds from stock option exercised by employees -41.38%4.55M-29.26%1.25M-79.30%71K-10.04%3.01M-90.43%221K0.14%7.77M-15.37%1.77M-83.22%343K6.59%3.35M377.27%2.31M
Net other financing activities 42.51%-165K----------------80.30%-287K------------108.35%100K
Cash from discontinued financing activities
Financing cash flow -41.34%4.39M-24.82%1.26M-88.81%31K-7.46%2.94M-93.52%152K-78.48%7.48M-16.46%1.68M-86.05%277K3.21%3.18M-91.53%2.34M
Net cash flow
Beginning cash position -69.90%261.29M-44.04%264.33M-53.82%317.18M-78.58%180.47M-69.90%261.29M138.84%867.97M-52.00%472.35M-55.01%686.86M0.82%842.61M138.84%867.97M
Current changes in cash 109.46%57.4M125.76%54.37M75.36%-52.85M187.77%136.7M-218.70%-80.82M-220.24%-606.68M-81.95%-211.06M60.48%-214.51M-122.54%-155.75M-105.37%-25.36M
End cash Position 21.97%318.7M21.97%318.7M-44.04%264.33M-53.82%317.18M-78.58%180.47M-69.90%261.29M-69.90%261.29M-52.00%472.35M-55.01%686.86M0.82%842.61M
Free cash flow 43.32%-453.65M17.74%-90.04M-8.96%-173.84M80.31%-78.51M16.12%-111.26M-150.17%-800.36M-585.38%-109.46M-261.30%-159.54M-142.44%-398.7M-124.83%-132.65M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MARA Holdings
MARA
+6.16%
Ecopetrol
EC
+3.44%
Oracle
ORCL
+2.80%
NVIDIA
NVDA
+1.92%
Apple
AAPL
+1.59%

Unlock the Full List